Gene expression profiling during the transition to failure in TNF-α over-expressing mice demonstrates the development of autoimmune myocarditis

Journal of Molecular and Cellular Cardiology

Volumn 36, Issue 4, 2004, Pages 515-530

  Tang, Zhonghua ^a   McGowan, Brian S ^a   Huber, Sally A ^b   McTiernan, Charles F ^c   Addya, Sankar ^d   Surrey, Saul ^d   Kubota, Toru ^e   Fortina, Paolo ^a   Higuchi, Yoshihiro ^a   Diamond, Maura A ^a   Wyre, Dwayne S ^a   Feldman, Arthur M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

Cardiomyopathy; Cytokines; Gene expression; Hypertrophy; Inflammation; Microarray

Indexed keywords

ANTIGEN; COMPLEMENTARY DNA; TUMOR NECROSIS FACTOR ALPHA;

AGE; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; ECHOCARDIOGRAPHY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FEMALE; GENDER; GENE CONTROL; GENE EXPRESSION; HEART; HEART FAILURE; HEART INJURY; HEART MUSCLE; HUMORAL IMMUNITY; IMMUNE RESPONSE GENE; IMMUNOGLOBULIN GENE; INFLAMMATION; MALE; MOLECULAR DYNAMICS; MOUSE; MYOCARDITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD45; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CARDIOMYOPATHIES; CD4-POSITIVE T-LYMPHOCYTES; CELL NUCLEUS; DNA, COMPLEMENTARY; DOWN-REGULATION; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HEART FAILURE, CONGESTIVE; HYPERTROPHY; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, TRANSGENIC; MYOCARDITIS; MYOCARDIUM; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, COMPLEMENTARY; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

MUS MUSCULUS;

EID: 11144355666     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.01.008     Document Type: Article

References (37)

1. Kubota T., McTiernan C.F., Frye C.S., Slawson S.E., Lemster B.H., Koretsky A.P., et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res. 81:1997;627-635.
2. Kubota T., Bounoutas G.S., Miyagishima M., Kadokami T., Sanders V.J., Bruton C., et al. Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation. 101:2000;2518-2525.
3. Li Y.Y., Feng Y.Q., Kadokami T., McTiernan C.F., Draviam R., Watkins S.C., et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci USA. 97:2000;12746-12751.
4. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
5. Barrans J.D., Stamatiou D., Liew C. Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. Biochem Biophys Res Commun. 280:2001;964-969.
6. Tan F.L., Moravec C.S., Li J., Apperson-Hansen C., McCarthy P.M., Young J.B., et al. The gene expression fingerprint of human heart failure. Proc Natl Acad Sci USA. 99:2002;11387-11392.
7. Yang J., Moravec C.S., Sussman M.A., DiPaola N.R., Fu D., Hawthorn L., et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation (Online). 102:2000;3046-3052.
8. Barrans J.D., Allen P.D., Stamatiou D., Dzau V.J., Liew C.C. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol. 160:2002;2035-2043.
9. Hwang J.J., Allen P.D., Tseng G.C., Lam C.W., Fananapazir L., Dzau V.J., et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomic. 10:2002;31-44.
10. Aronow B.J., Toyokawa T., Canning A., Haghighi K., Delling U., Kranias E., et al. Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy. Physiol Genomic. 6:2001;19-28.
11. Stanton L.W., Garrard L.J., Damm D., Garrick B.L., Lam A., Kapoun A.M., et al. Altered patterns of gene expression in response to myocardial infarction. Circ Res. 86:2000;939-945.
12. Blaxall B.C., Spang R., Rockman H.A., Koch W.J. Differential myocardial gene expression in the development and rescue of murine heart failure. Physiol Genomic. 15:2003;105-114.
13. Kadokami T., McTiernan C.F., Kubota T., Frye C.S., Feldman A.M. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest. 106:2000;589-597.
14. Yue H., Eastman P.S., Wang B.B., Minor J., Doctolero M.H., Nuttall R.L., et al. An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acid Res. 29:2001;E41.
15. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 25:2001;402-408.
16. Kadokami T., Frye C., Lemster B., Wagner C.L., Feldman A.M., McTiernan C.F. Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model. Circulation. 104:2001;1094-1097.
17. Kubota T., Miyagishima M., Frye C.S., Alber S.M., Bounoutas G.S., Kadokami T., et al. Overexpression of tumor necrosis factor-alpha activates both anti- and pro-apoptotic pathways in the myocardium. J Mol Cell Cardiol. 33:2001;1331-1344.
18. Janczewski A.M., Kadokami T., Lemster B., Frye C.S., McTiernan C.F., Feldman A.M. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha. Am J Physiol Heart Circ Physiol. 284:2003;H960-H969.
19. Kubota T., McTiernan C.F., Frye C.S., Demetris A.J., Feldman A.M. Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. J Card Fail. 3:1997;117-124.
20. Li Y.Y., McTiernan C.F., Feldman A.M. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res. 46:2000;214-224.
21. Blum A., Miller H. Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med. 52:2001;15-27.
22. Sasayama S., Matsumori A., Kihara Y. New insights into the pathophysiological role for cytokines in heart failure. Cardiovasc Res. 42:1999;557-564.
23. Mann D.L. Tumor necrosis factor-induced signal transduction and left ventricular remodeling. J Card Fail. 8:2002;S379-S386.
24. Hwang D.M., Dempsey A.A., Lee C.Y., Liew C.C. Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics. 66:2000;1-14.
25. Hwang D.M., Dempsey A.A., Wang R.X., Rezvani M., Barrans J.D., Dai K.S., et al. A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation. 96:1997;4146-4203.
26. Friddle C.J., Koga T., Rubin E.M., Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci USA. 97:2000;6745-6750.
27. Conraads V.M., Bosmans J.M., Vrints C.J. Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia. Int J Cardiol. 85:2002;33-49.
28. Mari D., Di Berardino F., Cugno M. Chronic heart failure and the immune system. Clin Rev Allergy Immunol. 23:2002;325-340.
29. Yun J., Zuscik M.J., Gonzalez-Cabrera P., McCune D.F., Ross S.A., Gaivin R., et al. Gene expression profiling of alpha(1b)-adrenergic receptor-induced cardiac hypertrophy by oligonucleotide arrays. Cardiovasc Res. 57:2003;443-455.
30. Taylor L.A., Carthy C.M., Yang D., Saad K., Wong D., Schreiner G., et al. Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays. Circ Res. 87:2000;328-334.
31. Mukherjee S., Belbin T.J., Spray D.C., Iacobas D.A., Weiss L.M., Kitsis R.N., et al. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res. 91:2003;187-196.
32. Pummerer C.L., Luze K., Grassl G., Bachmaier K., Offner F., Burrell S.K., et al. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J Clin Invest. 97:1996;2057-2062.
33. Eriksson U., Kurrer M.O., Schmitz N., Marsch S.C., Fontana A., Eugster H.P., et al. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation. 107:2003;320-325.
34. Clark D.J., Cleman M.W., Pfau S.E., Rollins S.A., Ramahi T.M., Mayer C., et al. Serum complement activation in congestive heart failure. Am Heart J. 141:2001;684-690.
35. Kaya Z., Afanasyeva M., Wang Y., Dohmen K.M., Schlichting J., Tretter T., et al. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol. 2:2001;739-745.
36. Nabavi N., Freeman G.J., Gault A., Godfrey D., Nadler L.M., Glimcher L.H. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature. 360:1992;266-268.
37. Pinsky D.J., Cai B., Yang X., Rodriguez C., Sciacca R.R., Cannon P.J. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin Invest. 95:1995;677-685.